Cannabis Campaigners' Guide News Database result:


After you have finished reading this article you can click here to go back.

UK: Cancer patients in cannabis trial

The Scotsman

Thursday 17 Jan 2002

---

CLINICAL trials of a new range of cannabis-based medicines are to be
expanded to include patients with cancer pain, it was revealed
yesterday.

The treatments are already being given to patients with multiple
sclerosis as part of a Phase Three trials programme.

GW Pharmaceuticals, the British company developing the medicines, said
more than 100 patients with terminal cancer would take part in the study
at more than 20 UK centres.

Dr Geoffrey Guy, the executive chairman of GW Pharmaceuticals, said:
"Cannabis-based medicine has the potential to provide considerable
advantages over current medications to cancer patients. Around 40 per
cent of cancer sufferers at present have unmet needs in pain
suppression."

 

 

 

After you have finished reading this article you can click here to go back. 




This page was created by the Cannabis Campaigners' Guide.

Feel free to link to this page!